Congenital cytomegalovirus mortality in the United States, 1990-2006

• Published in: PLoS neglected tropical diseases Vol. 5; no. 4; p. e1140
• Main Authors: Bristow, Benjamin N, O'Keefe, Kaitlin A, Shafir, Shira C, Sorvillo, Frank J
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01.04.2011; Public Library of Science (PLoS)
• Subjects: African Americans; Age; Asymptomatic; Child; Child, Preschool; Children & youth; Congenital diseases; Control; Cytomegalovirus; Cytomegalovirus infections; Cytomegalovirus Infections - congenital; Cytomegalovirus Infections - mortality; Death Certificates; Demographic aspects; Economic aspects; Ethnic Groups; Ethnicity; Female; Funding; Humans; Infant; Infant, Newborn; Infections; Male; Medicine; Mortality; Native North Americans; Pregnancy; Prevention; Race; Risk Factors; Sexually transmitted diseases; STD; Tropical diseases; United States; United States - epidemiology; Vaccines; Viral infections; Womens health; United States; United States > US; Ethnic Groups; United States; Humans; Risk Factors; Child, Preschool; Cytomegalovirus Infections; Female; Infant; Male; Death Certificates; Child; Infant, Newborn
• ISSN: 1935-2735; 1935-2727; 1935-2735
• DOI: 10.1371/journal.pntd.0001140

Congenital cytomegalovirus (CMV) infection is the most common intrauterine infection in the United States disproportionately affecting minority races and those of lower socio-economic class. Despite its importance there is little information on the burden of congenital CMV-related mortality in the US. To measure congenital CMV-associated mortality in the US and assess possible racial/ethnic disparities, we reviewed national death certificate data for a 17-year period. Congenital CMV-associated deaths from 1990 through 2006 were identified from multiple-cause-coded death records and were combined with US census data to calculate mortality rates. A total of 777 congenital CMV-associated deaths occurred over the 17-year study period resulting in 56,355 years of age-adjusted years of potential life lost. 71.7% (557) of congenital CMV-associated deaths occurred in infants (age less than 1 year). Age-adjusted mortality rates stratified by race/ethnicity revealed mortality disparities. Age-adjusted rate ratios were calculated for each racial/ethnic group using whites as the reference. Native Americans and African Americans were 2.34 (95% CI, 2.11-2.59) and 1.89 (95% CI, 1.70-2.11) times respectively, more likely to die from congenital CMV than whites. Asians and Hispanics were 0.54 (95% CI, 0.44-0.66) and 0.96 (95% CI, 0.83-1.10) times respectively, less likely to die from congenital CMV than whites. Congenital CMV infection causes appreciable mortality in the US exacting a particular burden among African Americans and Native Americans. Enhanced surveillance and increased screening are necessary to better understand the epidemiology of congenital CMV infection in addition to acceleration of vaccine development efforts.